title: The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection.
abstract: Community-associated methicillin-resistant Staphylococcus aureus accounts for a large portion of the increased staphylococcal disease incidence and can cause illness ranging from mild skin infections to rapidly fatal sepsis syndromes. Currently, we have limited understanding of S. aureus-derived mechanisms contributing to bacterial pathogenesis and host inflammation during staphylococcal disease. Herein, we characterize an influential role for the saeR/S two-component gene regulatory system in mediating cytokine induction using mouse models of S. aureus pathogenesis. Invasive S. aureus infection induced the production of localized and systemic pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interleukin (IL)-6 and IL-2. In contrast, mice infected with an isogenic saeR/S deletion mutant demonstrated significantly reduced pro-inflammatory cytokine levels. Additionally, secreted factors influenced by saeR/S elicited pro-inflammatory cytokines in human blood ex vivo. Our study further demonstrated robust saeR/S-mediated IFN-γ production during both invasive and subcutaneous skin infections. Results also indicated a critical role for saeR/S in promoting bacterial survival and enhancing host mortality during S. aureus peritonitis. Taken together, this study provides insight into specific mechanisms used by S. aureus during staphylococcal disease and characterizes a relationship between a bacterial global regulator of virulence and the production of pro-inflammatory mediators.
authors: Department of Immunology/Infectious Diseases, Montana State University-Bozeman, Bozeman, Montana, United States of America.
authors: Robert L
authors: RL
authors: Watkins
authors: Kyler B
authors: KB
authors: Pallister
authors: Jovanka M
authors: JM
authors: Voyich
references: Mol Microbiol. 2003 Jun;48(6):1429-49
references: 12791129
references: Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S344-9
references: 18462089
references: N Engl J Med. 2005 Apr 7;352(14):1436-44
references: 15814879
references: Infect Immun. 1998 Mar;66(3):1017-22
references: 9488390
references: J Basic Microbiol. 1994;34(5):317-22
references: 7996397
references: Lancet. 2002 May 25;359(9320):1819-27
references: 12044378
references: Annu Rev Microbiol. 2001;55:77-104
references: 11544350
references: J Clin Invest. 1994 Nov;94(5):1815-22
references: 7962526
references: Microbiology (Reading). 2005 Jun;151(Pt 6):1789-1800
references: 15941988
references: J Leukoc Biol. 2007 Jan;81(1):1-5
references: 17032697
references: FEMS Immunol Med Microbiol. 1993 Aug;7(2):145-52
references: 8401426
references: J Bacteriol. 2006 Nov;188(22):7742-58
references: 17079681
references: Microbiology (Reading). 2003 Oct;149(Pt 10):2709-2717
references: 14523104
references: FEMS Microbiol Lett. 2007 Mar;268(1):98-105
references: 17263851
references: Infect Immun. 2006 Aug;74(8):4655-65
references: 16861653
references: FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):1-9
references: 14734180
references: JAMA. 1998 Feb 25;279(8):593-8
references: 9486753
references: Infect Immun. 1997 Apr;65(4):1550-6
references: 9119503
references: Lancet Infect Dis. 2009 May;9(5):281-90
references: 19393958
references: Immunology. 1998 Jan;93(1):80-5
references: 9536122
references: J Immunol. 2005 Sep 15;175(6):3907-19
references: 16148137
references: Infect Immun. 1995 Apr;63(4):1165-72
references: 7890367
references: Trends Immunol. 2007 Sep;28(9):408-18
references: 17681885
references: Infect Immun. 2002 Jan;70(1):127-33
references: 11748173
references: J Clin Microbiol. 2003 Nov;41(11):5113-20
references: 14605147
references: N Engl J Med. 2006 Aug 17;355(7):666-74
references: 16914702
references: JAMA. 1999 Sep 22-29;282(12):1123-5
references: 10501104
references: N Engl J Med. 2005 Apr 7;352(14):1445-53
references: 15814880
references: J Infect Dis. 2009 Jun 1;199(11):1698-706
references: 19374556
references: N Engl J Med. 1998 Aug 20;339(8):520-32
references: 9709046
references: J Infect Dis. 2006 Nov 1;194(9):1267-75
references: 17041853
references: Infect Immun. 2000 May;68(5):2424-30
references: 10768926
references: J Infect Dis. 2010 Mar 15;201(6):871-80
references: 20132035
references: Nat Med. 2009 May;15(5):496-7
references: 19424209
references: FEMS Microbiol Lett. 2010 Jul;308(2):175-84
references: 20528938
references: Nat Rev Immunol. 2008 Oct;8(10):776-87
references: 18802444
references: N Engl J Med. 2005 Feb 3;352(5):468-75
references: 15689585
references: Nature. 2002 Dec 19-26;420(6917):885-91
references: 12490963
references: J Immunol. 2008 Jul 15;181(2):1323-32
references: 18606687
references: FEMS Microbiol Rev. 2004 May;28(2):183-200
references: 15109784
references: J Allergy Clin Immunol. 2010 Jan;125(1):39-49
references: 20109735
references: Lancet. 2002 Mar 2;359(9308):753-9
references: 11888586
references: J Clin Invest. 2009 Sep;119(9):2464-74
references: 19729844
references: N Engl J Med. 2003 Apr 17;348(16):1546-54
references: 12700374
references: J Infect Dis. 2010 Jan 15;201(2):241-54
references: 20001858
references: Clin Microbiol Rev. 2000 Jan;13(1):16-34, table of contents
references: 10627489
references: JAMA. 2007 Oct 17;298(15):1763-71
references: 17940231
references: N Engl J Med. 2005 Sep 22;353(12):1245-51
references: 16177250
references: Lancet. 2006 Jul 8;368(9530):157-69
references: 16829300
references: Shock. 2008 Oct;30 Suppl 1:3-9
references: 18704017
references: Can J Microbiol. 1996 Feb;42(2):120-3
references: 8742355
references: J Pathol. 2008 Jan;214(2):211-23
references: 18161754